Entity

Time filter

Source Type

BDC
Bhopal, India

Sharma S.,Sapience Bio Analytical Research Laboratory SBRL | Sharma G.K.,BDC | Mehta A.,P.A. College
Asian Journal of Pharmaceutical and Clinical Research | Year: 2012

Herbs have always been used as a common source of medicines, the Ficus benghalensis is an important herbal plant used in Ayurveda as a traditional medicinal system of India. In the present investigations, the preventive effect of Ficus benghalensis bark extract was evaluated against cyclophosphamide induced of chromosomal Abbreviation and micronucleus formation in the rat bone marrow cells. The single p.o administration of Ficus benghalensis bark ext at the dose of 250, 500 and 800 mg/kg body weight, 24 hours prior the administration of cyclophosphamide (at the dose of 50 mg/kg) have significantly prevented the micronucleus formations and Chromosomal Abbreviation in dose dependent manner in bone marrow cells of rat as compared to cyclophosphamide group. It is seems to have a preventive potential against CP-induced mutagenic effect in rat bone marrow cells. Source


News Article
Site: http://www.scientificcomputing.com/rss-feeds/all/rss.xml/all

PALO ALTO, CA — D-Wave Systems, the world's first quantum computing company, announced that Los Alamos National Laboratory will acquire and install the latest D-Wave quantum computer, the 1000+ qubit D-Wave 2X system. Los Alamos, a multidisciplinary research institution engaged in strategic science on behalf of national security, will lead a collaboration within the Department of Energy and with select university partners to explore the capabilities and applications of quantum annealing technology, consistent with the goals of the government-wide National Strategic Computing Initiative. The National Strategic Computing Initiative, created by executive order of President Barack Obama in late July, is intended "to maximize [the] benefits of high-performance computing (HPC) research, development, and deployment." "Eventually, Moore's Law (that predicted that the number of transistors on an integrated circuit would double every two years) will come to an end," said John Sarrao, associate director for Theory, Simulation, and Computation at Los Alamos. "Dennard Scaling (that predicted that performance per watt of computing would grow exponentially at roughly the same rate) already has. Beyond these two observations lies the end of the current 'conventional' computing era, so new technologies and ideas are needed." D-Wave's quantum annealing technology leverages quantum effects to quickly find the lowest points in a virtual "energy landscape." These low points correspond to optimal or near optimal solutions to a given problem. In addition, D-Wave's superconducting processor generates almost no heat, so the system's power requirements, currently less than 25 kW, will remain low as the computer continues to scale. This is in stark contrast to current supercomputers that can require many megawatts of power, a huge impediment as the need for computational resources continues to grow. "As conventional computers reach their limits in terms of scaling and performance per watt, we need to investigate new technologies to support our mission," said Mark Anderson of the Laboratory's Weapons Physics Directorate. "Researching and evaluating quantum annealing as the basis for new approaches to address intractable problems is an essential and powerful step, and will enable a new generation of forward thinkers to influence its evolution in a direction most beneficial to the nation." "Los Alamos is a global leader in high-performance computing and a pioneer in the application of new architectures to solve critical problems related to national security, energy, the environment, materials, health and earth science," said Robert "Bo" Ewald, president of D-Wave U.S. "As we work jointly with scientists and engineers at Los Alamos, we expect to be able to accelerate the pace of quantum software development to advance the state of algorithms, applications and software tools for quantum computing." The D-Wave 2X system is expected to be installed at Los Alamos in early 2016. About D-Wave Systems D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing and computer science into breakthrough approaches to computation to help solve some of the world's most complex challenges. The company's quantum computers are built using a novel type of superconducting processor that uses quantum mechanics to massively accelerate computation. D-Wave's customers include some of the world's most prominent organizations including Lockheed Martin and Google, whose system is hosted at NASA's Ames Research Center. With headquarters near Vancouver, Canada, D-Wave U.S. is based in Palo Alto, California. D-Wave has a blue-chip investor base including Bezos Expeditions, BDC Capital, DFJ, Goldman Sachs, Growthworks, Harris & Harris Group, In-Q-Tel, International Investment and Underwriting, and Kensington Partners Limited.


Home > Press > Los Alamos National Laboratory Orders a 1000+ Qubit D-Wave 2X Quantum Computer: Los Alamos to explore new methods of computing as part of new U.S. Government National Strategic Computing Initiative Abstract: D-Wave Systems Inc., the world's first quantum computing company, announced that Los Alamos National Laboratory will acquire and install the latest D-Wave quantum computer, the 1000+ qubit D-Wave 2X™ system. Los Alamos, a multidisciplinary research institution engaged in strategic science on behalf of national security, will lead a collaboration within the Department of Energy and with select university partners to explore the capabilities and applications of quantum annealing technology, consistent with the goals of the government-wide National Strategic Computing Initiative. The National Strategic Computing Initiative, created by executive order of President Obama in late July, is intended "to maximize [the] benefits of high-performance computing (HPC) research, development, and deployment." "Eventually Moore’s Law (that predicted that the number of transistors on an integrated circuit would double every two years), will come to an end," said John Sarrao, associate director for Theory, Simulation, and Computation at Los Alamos. "Dennard Scaling (that predicted that performance per watt of computing would grow exponentially at roughly the same rate) already has. Beyond these two observations lies the end of the current 'conventional' computing era, so new technologies and ideas are needed." “As conventional computers reach their limits in terms of scaling and performance per watt, we need to investigate new technologies to support our mission,” said Mark Anderson of the Laboratory's Weapons Physics Directorate. “Researching and evaluating quantum annealing as the basis for new approaches to address intractable problems is an essential and powerful step, and will enable a new generation of forward thinkers to influence its evolution in a direction most beneficial to the nation." “Los Alamos is a global leader in high performance computing and a pioneer in the application of new architectures to solve critical problems related to national security, energy, the environment, materials, health and earth science," said Robert "Bo" Ewald, president of D-Wave U.S. “As we work jointly with scientists and engineers at Los Alamos we expect to be able to accelerate the pace of quantum software development to advance the state of algorithms, applications and software tools for quantum computing.” D-Wave's quantum annealing technology leverages quantum effects to quickly find the lowest points in a virtual “energy landscape." These low points correspond to optimal or near optimal solutions to a given problem. In addition, D-Wave's superconducting processor generates almost no heat, so the system's power requirements, currently less than 25 kW, will remain low as the computer continues to scale. This is in stark contrast to current supercomputers that can require many megawatts of power, a huge impediment as the need for computational resources continues to grow. The D-Wave 2X system is expected to be installed at Los Alamos in early 2016. About D-Wave Systems Inc. D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing and computer science into breakthrough approaches to computation to help solve some of the world's most complex challenges. The company's quantum computers are built using a novel type of superconducting processor that uses quantum mechanics to massively accelerate computation. D-Wave's customers include some of the world's most prominent organizations including Lockheed Martin and Google, whose system is hosted at NASA's Ames Research Center. With headquarters near Vancouver, Canada, D-Wave U.S. is based in Palo Alto, California. D-Wave has a blue-chip investor base including Bezos Expeditions, BDC Capital, DFJ, Goldman Sachs, Growthworks, Harris & Harris Group, In-Q-Tel, International Investment and Underwriting, and Kensington Partners Limited. For more information, please click If you have a comment, please us. Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.


News Article
Site: http://phys.org/biology-news/

The new crop could have huge implications for the global lubricant market – it is estimated that half of all lubricants sold world-wide end up in the environment. Currently there are few alternatives available to the mineral-based products that can be harmful pollutants. The new oilseed rape (OSR) will not only provide a high-quality renewable alternative, but will have low toxicity and be biodegradable. OSR is the third-largest crop by area in the UK and is used as a break crop in wheat production. Sold both as a foodstuff and for biodiesel, growers are vulnerable to changes in EU policy, which could significantly affect the crop's market value. This new crop has the potential to protect growers from future market fluctuations by opening up a new multi-billion pound market for rapeseed oil as a biolubricant. Professor Ian Bancroft, from the Centre for Novel Agricultural Products which is based in the University of York's Department of Biology, said: "Our research focuses on the relationships between genome evolution and the control of plant characteristics that are of relevance to food security, health, conservation or sustainability. This project is a great example of harnessing our knowledge of genomics to do just that." The project is being developed by a collaboration of researchers and plant breeders, led by Velcourt. It is being funded by Innovate UK and the Biotechnology and Biological Sciences Research Council. Other research partners include the University of York, Biorenewables Development Centre (BDC) and Limagrain UK. Keith Norman, Technical Director at Velcourt said: "The type of OSR we are investigating is hugely exciting not only because it is food grade and less harmful to the environment, but also because it is thermally-stable which has been a barrier to previous biolubricants." Helen Shiels, Business Development Manager at the BDC, added: "We will be producing novel oils for industry evaluation and would urge any interested companies to get in touch to explore how they might be able to assess this new product for their applications." Explore further: Genome sequence of mesopolyploid crop Brassica rapa could improve important agricultural crops


Home > Press > ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center Abstract: Harris & Harris Group, Inc. (NASDAQ:TINY), an investor in transformative companies enabled by disruptive science, wanted to let you know that its portfolio company, ORIG3N, Inc., will join three of its other portfolio companies, D-Wave Systems, Inc., HZO. Inc., and Metabolon, Inc. in the morning of presentations on Tuesday, June 7, 2016, at the New York Genome Center, 101 Ave of the Americas, New York, NY 10013, from 8:30 a.m. to 12:00 p.m. ET. These presentations will be followed by Harris & Harris Group's Annual Meeting of Shareholders which the Board of Directors has set for the same day, June 7, 2016, beginning at 12:00 p.m. ET. In addition to a brief presentation, ORIG3N will be collecting blood from willing volunteers to add to its LifeCapsule repository, which is the world's largest blood cell repository dedicated to supporting regenerative medicine. In addition, the company will be offering its LifeProfile tests, which are a series of genetic tests that show how your genes impact specific areas of lifestyle including fitness potential and insights about skin. If you are interested in attending, and have not already registered, please register at https://hhvc.regfox.com/june2016event. Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com and on Facebook at www.facebook.com/harrisharrisvc. About Harris & Harris Group Harris & Harris Group is a publicly traded, internally managed business development company that builds transformative companies from disruptive science. Detailed information about Harris & Harris Group and its holdings can be found on its website at www.HHVC.com, on Facebook at www.facebook.com/harrisharrisvc and by following on Twitter @harrisandharrisgroup. About ORIG3N, Inc. ORIG3N is a biotechnology company developing a breakthrough disease-modeling platform targeting rare genetically inherited diseases. By advancing screening projects using iPSC-derived differentiated cells and rapidly delivering the resulting data to inform therapeutic decisions, ORIG3N will replace trial and error guess work of treating disease and enable longer, healthier lives. The founders are serial entrepreneurs who's previous venture, ArtusLabs, was acquired by PerkinElmer in 2011. For more information, visit: www.orig3n.com. About D-Wave Systems, Inc. D-Wave Systems is a quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing and computer science into breakthrough approaches to computation to help solve some of the world's most complex challenges. The company's quantum computers are built using a novel type of superconducting processor that uses quantum mechanics to massively accelerate computation. D-Wave's customers include some of the world's most prominent organizations including Lockheed Martin and Google, whose system is hosted at NASA's Ames Research Center. With headquarters near Vancouver, Canada, D-Wave U.S. is based in Palo Alto, California. D-Wave has a blue-chip investor base including Bezos Expeditions, BDC Capital, DFJ, Goldman Sachs, Growthworks, Harris & Harris Group, In-Q-Tel, International Investment and Underwriting, and Kensington Partners Limited. For more information, visit: www.dwavesys.com. About HZO, Inc. HZO is a technology solutions and licensing company that protects electronics from damage caused by liquid submersion, corrosive environments, humidity, sweat, dust and debris. The company provides a powerful thin-film technology for electronics' manufacturers and device makers in sectors ranging from consumer and automotive to LEDs and industrial. With an emphasis on building its patent portfolio and over 150 unique product validations, HZO enables product design freedom and creates product differentiation by performing reliably well beyond defined electronics testing standards like IPX7. With scalable end-to-end solutions that support mass volume production, and a world-class technical team dedicated to innovation and customer success, HZO works with top brands like Motorola, Dell, Nike and Deutsche Telekom to deliver electronics that can be used in all conditions and environments. For more information and contact info, visit http://www.hzo.com. About Metabolon, Inc. Metabolon is a health technology company focused on metabolomics - a powerful tool for assessing health. Its proprietary platforms and informatics are delivering biomarker discoveries, innovative diagnostic tests, breakthroughs in precision medicine, and ground-breaking partnerships in genomics-based health initiatives. Metabolon's expertise is also accelerating research and product development across the pharmaceutical, biotechnology, consumer products, agriculture and nutrition industries, as well as academic and government organizations. Founded in 2000 and headquartered in Research Triangle Park, North Carolina, the company has conducted more than 4,000 independent and collaborative studies, resulting in over 500 peer-reviewed publications. For more information, please visit www.metabolon.com. Additional Information Regarding Annual Meeting Solicitation The Company filed a definitive proxy statement and related materials with the Securities and Exchange Commission ("SEC") in connection with its 2016 Annual Meeting of Shareholders (the "Annual Meeting") on April 20, 2016. SHAREHOLDERS ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), AND ANY OTHER RELEVANT DOCUMENTS IN CONNECTION WITH THE ANNUAL MEETING THAT THE COMPANY WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE, BECAUSE THESE MATERIALS WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE ANNUAL MEETING. Shareholders are able to obtain a free copy of that definitive proxy statement and other materials that the Company filed with the SEC at the SEC's website at www.sec.gov. That definitive proxy statement and these other materials will also be available free of charge by directing a request to Harris & Harris Group, Inc., Attn: Investor Relations, 1450 Broadway, 24th Floor, New York, NY 10018, or from the Company at www.hhvc.com. The Company, its directors and its named executive officers may be deemed to be participants in the solicitation of proxies from the Company's shareholders in connection with the Annual Meeting. Shareholders may obtain information regarding the names, affiliations and interests of such individuals in the Company's proxy statement filed on April 20, 2016, for the 2016 Annual Meeting of Shareholders. To the extent that holdings of the Company's securities on the part of those individuals have changed since the date of that proxy statement, those changes have been reflected on Statements of Changes in Ownership on Forms 3 or 4 filed with the Securities and Exchange Commission. More current information regarding the interests of the directors and named executive officers of Harris & Harris Group will be contained in the definitive proxy statement referred to in the preceding paragraph. Forward-Looking Statements This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release. Please see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2015, as well as subsequent filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including, but not limited to, the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The references and links to the websites www.HHVC.com, www.dwavesys.com, www.hzo.com, www.metabolon.com, www.orig3n.com, www.sec.gov and www.facebook.com have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Harris & Harris Group is not responsible for the contents of third party websites. For more information, please click If you have a comment, please us. Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Discover hidden collaborations